Sanara MedTech Inc. (SMTI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SMTI currently has 8.99M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 10.1% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 9.0M shares outstanding |
9M | 0 |
| Mar 24, 2026 |
10-K filing | 8.6M shares outstanding |
8.6M | 0 |
| Nov 12, 2025 |
10-Q filing | 8.9M shares outstanding |
8.9M | 0 |
| Aug 13, 2025 |
10-Q filing | 8.6M shares outstanding |
8.6M | 0 |
| May 14, 2025 |
10-Q filing | 8.6M shares outstanding |
8.6M | 0 |
| Mar 25, 2025 |
10-K filing | 8.5M shares outstanding |
8.5M | 0 |
| Jan 22, 2025 |
8-K filing: The Company entered into a Share Subscription and Shareholders' Agreement with Biomimetic Innovation Limited (BMI) and its shareholders, agreeing to contribute up to approximately €8.0 million to BMI in exchange for 16,460 ordinary shares of BMI, constituting approximately 12.5% of the outstanding equity of BMI, with an initial cash investment of approximately €3.0 million and conversion of a convertible loan of €1.0 million into equity, totaling approximately €4.0 million invested on January 16, 2025. ($4.34M proceeds) |
8.5M | 0 |
| Nov 12, 2024 |
10-Q filing | 8.5M shares outstanding |
8.5M | 0 |
| Sep 11, 2024 |
8-K filing: Sanara CMP LLC, a subsidiary of the Company, purchased 100,674.72 common units in ChemoMouthpiece, LLC for $5.0 million, representing approximately 6.64% of the issued and outstanding membership interests of CMp. The Company also borrowed an additional $15.5 million under its Term Loan Agreement, using $5.0 million for the investment in CMp. ($5.0M proceeds) |
8.5M | 0 |
| Aug 12, 2024 |
10-Q filing | 8.5M shares outstanding |
8.5M | 0 |
| May 21, 2024 |
S-3 filing: Sanara MedTech Inc. files an S-3 form relating to the resale of up to 255,049 shares of common stock by selling shareholders. |
8.4M | 0 |
| May 13, 2024 |
10-Q filing | 8.4M shares outstanding |
8.4M | 0 |
| Mar 25, 2024 |
10-K filing | 8.3M shares outstanding |
8.3M | 0 |
| Nov 13, 2023 |
10-Q filing | 8.3M shares outstanding |
8.3M | 0 |
| Aug 14, 2023 |
10-Q filing | 8.2M shares outstanding |
8.2M | 0 |
| Aug 02, 2023 |
8-K filing: Sanara MedTech Inc. acquired certain assets of The Hymed Group Corporation and Applied Nutritionals, LLC for $15.25 million, including $9.75 million in cash, 73,809 shares of common stock valued at $3.0 million, and $2.5 million in cash installments, while also entering into a loan agreement for $12.0 million and a professional services agreement with Dr. George D. Petito. ($3.0M proceeds) |
8.2M | 0 |
| May 15, 2023 |
10-Q filing | 8.2M shares outstanding |
8.2M | 0 |
| Mar 20, 2023 |
10-K filing | 7.9M shares outstanding |
7.9M | 0 |
| Nov 14, 2022 |
10-Q filing | 8.1M shares outstanding |
8.1M | 0 |
| Aug 15, 2022 |
10-Q filing | 7.8M shares outstanding |
7.8M | 0 |
| Jul 05, 2022 |
8-K filing: Sanara MedTech Inc. acquired 100% of the issued and outstanding membership interests in Scendia Biologics, LLC, completing the acquisition on July 1, 2022. ($6.0M proceeds) |
7.6M | 0 |
| May 16, 2022 |
10-Q filing | 7.6M shares outstanding |
7.6M | 0 |
| Apr 08, 2022 |
8-K filing: Sanara MedTech Inc. completed the acquisition of Precision Healing Inc. through a merger, issuing shares and warrants to Precision Healing equity holders and assuming options. |
7.3M | 0 |
| Mar 31, 2022 |
10-K filing | 7.3M shares outstanding |
7.3M | 0 |
| Nov 12, 2021 |
10-Q filing | 6.3M shares outstanding |
6.3M | 0 |
| Aug 16, 2021 |
10-Q filing | 6.3M shares outstanding |
6.3M | 0 |
| May 14, 2021 |
10-Q filing | 7.6M shares outstanding |
7.6M | 0 |
| Mar 30, 2021 |
10-K filing | 5.7M shares outstanding |
5.7M | 0 |
| Dec 23, 2020 |
S-3 filing: The filing registers an indeterminate number of shares of common and preferred stock, warrants, and units for potential issuance. |
5.7M | 0 |
| Nov 13, 2020 |
10-Q filing | 5.7M shares outstanding |
5.7M | 0 |
| Aug 13, 2020 |
10-Q filing | 6.2M shares outstanding |
6.2M | 0 |
| May 12, 2020 |
10-Q filing | 6.2M shares outstanding |
6.2M | 0 |
| Mar 26, 2020 |
10-K filing | 3.6M shares outstanding |
3.6M | 0 |